Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
RadNet | RDNT | Apr 17, 2025 | 49.78 | -1.46 |
Radware | RDWR | Apr 17, 2025 | 21.28 | +1.02 |
Rafael B | RFL | Apr 17, 2025 | 1.68 | +5.00 |
Rail Vision | RVSN | Apr 17, 2025 | 0.41 | -3.77 |
Rallybio | RLYB | Apr 17, 2025 | 0.25 | -0.71 |
Ralph Lauren | RL | Apr 17, 2025 | 206.50 | +2.20 |
Ramaco Resources A | METC | Apr 17, 2025 | 9.87 | +4.39 |
Ramaco Resources B | METCB | Apr 17, 2025 | 8.18 | +4.20 |
Rambus | RMBS | Apr 17, 2025 | 45.72 | -0.44 |
Rand Capital | RAND | Apr 17, 2025 | 19.80 | +2.86 |
Range Capital Acquisition | RANG | Apr 17, 2025 | 10.04 | 0.00 |
Range Capital Acquisition Unit | RANGU | Apr 17, 2025 | 10.22 | +0.20 |
Range Resources | RRC | Apr 17, 2025 | 34.18 | +0.23 |
Ranger Energy Services A | RNGR | Apr 17, 2025 | 12.62 | +1.94 |
Rani Therapeutics A | RANI | Apr 17, 2025 | 1.17 | +1.74 |
Ranpak A | PACK | Apr 17, 2025 | 3.50 | -2.23 |
Rapid Micro Biosystems A | RPID | Apr 17, 2025 | 2.40 | +5.26 |
Rapid7 | RPD | Apr 17, 2025 | 22.56 | -1.18 |
Rapport Therapeutics | RAPP | Apr 17, 2025 | 10.15 | +4.00 |
RAPT Therapeutics | RAPT | Apr 17, 2025 | 0.79 | -1.32 |
Rare Earth/Str Metals ETF Market Vectors | REMX | Apr 17, 2025 | 37.16 | +0.49 |
Rave Restaurant Group | RAVE | Apr 17, 2025 | 2.27 | +3.65 |
Raymond James Financial | RJF | Apr 17, 2025 | 133.46 | +0.97 |
Raymond James Financial B | RJF-B | Apr 17, 2025 | 25.05 | 0.00 |
Rayonier Advanced Materials | RYAM | Apr 17, 2025 | 4.40 | -0.90 |
Rayonier REIT | RYN | Apr 17, 2025 | 25.28 | +0.88 |
Raytech Holding | RAY | Apr 17, 2025 | 2.55 | +0.39 |
RB Global | RBA | Apr 17, 2025 | 97.38 | +0.83 |
RBB Bancorp | RBB | Apr 17, 2025 | 15.08 | -1.82 |
RBC Bearings | RBC | Apr 17, 2025 | 321.68 | +0.53 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.